XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies - Summary of Accrued expense (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Compensation $ 3,489 $ 3,355
Clinical study related costs 2,636 1,636
Facility Expansion Costs 1,161 0
Accrued legal costs 1,621 436
Investment purchases payable 7,500 0
Manufacturing improvement costs 2,921 678
Accrued consulting and professional fees 1,075 1,210
Other accrued expenses 542 21
Total accrued expenses and other $ 20,945 $ 7,336